3467704

Organization name

Labsystems Diagnostics Oy

SRN

FI-MF-000018281

Manufacturer status

Active

9 warnings recorded — scroll inside the panel to see all entries.

• CW010

  EUDAMED did not publish a description for this code.
• CW076

  EUDAMED did not publish a description for this code.
• CW080

  EUDAMED did not publish a description for this code.
• CW088

  EUDAMED did not publish a description for this code.
• CW100

  EUDAMED did not publish a description for this code.
• CW175

  EUDAMED did not publish a description for this code.
• CW422

  EUDAMED did not publish a description for this code.
• CW401

  EUDAMED did not publish a description for this code.
• CW292

  EUDAMED did not publish a description for this code.

Primary placement in Finland; available across 1 country total.

Placed on the market in Finland; per-country availability dates not published.

Trade name

not provided

UDI-DI code

06438172401068

Basic UDI-DI

B-06438172401068

Reference / catalog number

3467704

Issuing entity

GS1

Risk category

IVDD — General

Applicable legislation

IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

NeoMass CAH Mobile Phase A is an accessory kit component of Labsystems Diagnostics’ NeoMass CAH Kit (Order No: 7150022) to be used for the detection of Congenital Adrenal Hyperplasia (CAH) in newborns.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• W01019099CLINICAL CHEMISTRY REAGENTS - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification